Among rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.
The coronavirus disease 2019 pandemic has presented pharmacy students with an opportunity to develop new skills that former students never had the opportunity to develop.
Although the demand for generic competition in the biopharmaceutical market could potentially be great, regulators have been slow to clear a pathway for the approval of generic biopharmaceuticals.
To improve the care of patients with hemophilia and von Willebrand's Disease (vWD), coagulation factor products should be billed through the pharmacy benefit and provided by specialty pharmacies, the authors of a new study suggest.
Among psoriasis patients initiated on oral nonbiologic or on biologic therapy, most patients undergo at least 1 therapy change within 4 months of treatment initiation.
This study developed and tested predictive models of opioid abuse using Humana commercial membership data that were subsequently tested in the Truven commercial data set.
These tips can help recent pharmacy school graduates navigate the professional world.
Previously, vaccination was not recommended for patients in a certain age range, as there was no demonstrated benefit to HPV vaccination; however, this is about to change.
How do we achieve optimal results for patients? This vision includes strategies and steps for a broader system of care based on the premise that health care professionals cannot go it alone.
Three studies published last year provide useful information on risk factors for colds, which affect adults 2 to 3 times a year.
Neuropathic pain is a chronic nerve pain that can significantly impair a patient's functioning and quality of life.
With expanding pharmacy practice, it is time to explore conflict management, and its necessity in this current climate.
This study evaluated the rates of dose escalation in patients with Crohn's disease.
Peanut allergies affect approximately 1.2% of the entire US population and an estimated 2.5% of the childhood population.
We describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.
In this retrospective chart review, patients with hepatitis C had a sustained virologic response with either dual or triple therapy.
An estimation and comparison of the cost of home phototherapy versus biologics over a 3-year time horizon in patients with moderate-to-severe plaque psoriasis.
The 340B Drug Pricing Program contains several complexities that covered entities are expected to govern and oversee.
Higher drug costs may be attributable to either high initial doses or a dose increase.
Taking advantage of all the value that nonpharmacy organizations have to offer.
Despite the availability of such products, obesity continues to signifi- cantly contribute to morbidity and mortality in the United States.